慢性過敏性肺炎の予後トランスクリプトームシグネチャ (PREDICT-HP)
慢性過敏性肺炎の予後トランスクリプトーム署名の開発と検証
Up to 150 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
調査の概要
状態
状態
条件
条件
詳細な説明
Hypersensitivity pneumonitis is an immunologically mediated form of lung disease, resulting from inhalation exposure to a large variety of antigens. For unknown reasons, a subgroup of patients with HP without a known inciting antigen exposure develops chronic disease with progressive pulmonary fibrosis (the leading cause of death). Accurately identifying patients at risk of disease progression is necessary for prognosis and therapy.
Enrolled subjects will be followed for 24 months and complete 5 visits to one of the study centers. Blood biomarkers will be collected in addition to other clinical data to determine if these biomarkers can predict disease progression.
研究の種類
研究の種類
入学 (実際)
入学
連絡先と場所
研究場所
-
-
Arizona
-
Tucson、Arizona、アメリカ、85719
- University of Arizona
-
-
California
-
Sacramento、California、アメリカ、95817
- University of California Davis
-
-
Colorado
-
Denver、Colorado、アメリカ、80206
- National Jewish Health
-
-
Illinois
-
Chicago、Illinois、アメリカ、60637
- University of Chicago
-
-
Minnesota
-
Rochester、Minnesota、アメリカ、55905
- Mayo Clinic
-
-
Texas
-
Dallas、Texas、アメリカ、75390
- University of Texas Southwestern
-
-
Utah
-
Salt Lake City、Utah、アメリカ、84108
- University of Utah
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
The study population consists of men and women aged 18 to 85 years old with a diagnosis of chronic hypersensitivity pneumonitis.
説明
Inclusion Criteria:
- Diagnosis of chronic hypersensitivity pneumonitis
- Age 18 through 85 years.
- Diagnosis of chronic hypersensitivity pneumonitis by HRCT
- Able to understand and sign a written informed consent form.
- Able to understand the importance of adherence to the study protocol and willing to follow all study requirements
Exclusion Criteria:
- Not a suitable candidate for enrollment or unlikely to comply with the requirements of this study
- Known explanation for the interstitial lung disease
- Clinical diagnosis of any connective tissue disease
- Listed or expected to receive a lung transplant within 4 months from enrollment
- Pregnant women
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:CASE_ONLY
- 時間の展望:PROSPECTIVE
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
絶対 FVC (予測される割合) が 10% 以上低下するまでの時間
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
絶対 DLCO (予測される割合) が 10% 以上低下するまでの時間
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
相対 FVC (予測される割合) が 10% 以上低下するまでの時間
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
相対 DLCO (予測パーセント) 低下までの時間 ≥10%
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
相対 DLCO (予測パーセント) 低下までの時間 ≥15%
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
最初に判定された急性慢性過敏性肺炎の増悪までの時間
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
経口または静脈内ステロイドの新しいコースの必要性
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
あらゆる原因による死亡までの時間
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
12 か月目の St. George's Respiratory Questionnaire 活動スコアを使用した呼吸困難のベースラインからの変化
時間枠:12ヶ月
|
12ヶ月
|
|
|
6 か月目のベースラインからの徒歩 6 分の距離の変化
時間枠:6ヵ月
|
6ヵ月
|
|
|
12 か月目のベースラインからの徒歩 6 分の距離の変化
時間枠:12ヶ月
|
12ヶ月
|
|
|
18 か月目のベースラインからの徒歩 6 分の距離の変化
時間枠:18ヶ月
|
18ヶ月
|
|
|
24 か月目のベースラインからの徒歩 6 分の距離の変化
時間枠:24ヶ月
|
24ヶ月
|
|
|
24 か月間の FVC の減少率 (予測パーセント)
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
24 か月間の FVC (ml) の減少率
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
24 か月間の DLCO の減少率 (予測パーセント)
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
24 か月間の DLCO の減少率 (mmol/min/kpa)
時間枠:24ヶ月まで
|
24ヶ月まで
|
|
|
Change from baseline in St. George's Respiratory Questionnaire total score at month 6
時間枠:6 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
6 months
|
|
Change from baseline in St. George's Respiratory Questionnaire total score at month 12
時間枠:12 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
12 months
|
|
Change from baseline in St. George's Respiratory Questionnaire total score at month 18
時間枠:18 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
18 months
|
|
Change from baseline in St. George's Respiratory Questionnaire total score at month 24
時間枠:24 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
24 months
|
|
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 6
時間枠:6 months
|
Scores range from 0 to 120, with higher scores indicating greater breathlessness. |
6 months
|
|
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 12
時間枠:12 months
|
Scores range from 0 to 120, with higher scores indicating greater breathlessness. |
12 months
|
|
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 18
時間枠:18 months
|
Scores range from 0 to 120, with higher scores indicating greater breathlessness. |
18 months
|
|
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 24
時間枠:24 months
|
Scores range from 0 to 120, with higher scores indicating greater breathlessness. |
24 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 6
時間枠:6 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
6 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 12
時間枠:12 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
12 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 18
時間枠:18 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
18 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 24
時間枠:24 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
24 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 6
時間枠:6 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
6 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 18
時間枠:18 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
18 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 24
時間枠:24 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
24 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 6
時間枠:6 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
6 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 12
時間枠:12 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
12 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 18
時間枠:18 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
18 months
|
|
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 24
時間枠:24 months
|
The total score ranges from 0 to 100, with higher scores indicating worse health-related quality of life. |
24 months
|
|
Change from baseline in CT visual (≥10 percent) score at month 12
時間枠:12 months
|
Visual scores range from 0 to 100, with higher scores indicating more lung fibrosis. |
12 months
|
|
Change from baseline in CT visual (≥10 percent) score at month 24
時間枠:24 months
|
Visual scores range from 0 to 100, with higher scores indicating more lung fibrosis. |
24 months
|
|
Change from baseline in CT quantitative (≥3.4) score at month 12
時間枠:12 months
|
CT quantitative scores range from 0 to no upper limits, with higher scores indicating more lung fibrosis. |
12 months
|
|
Change from baseline in CT quantitative (≥3.4) score at month 24
時間枠:24 months
|
CT quantitative scores range from 0 to no upper limits, with higher scores indicating more lung fibrosis. |
24 months
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Evans Fernández, MD, MS、National Jewish Health
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。